Hanus; Lumir
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hanus; Lumir.The latest application filed is for "resorcinol derivatives and their use for lowering blood pressure".
- Hanus; Lumir - Jerusalem IL
| Patent | Date |
|---|---|
| Pharmaceutical compositions comprising cannabidiol derivatives Grant 7,759,526 - Mechoulam , et al. July 20, 2 | 2010-07-20 |
| Resorcinol Derivatives and Their Use for Lowering Blood Pressure App 20080275135 - Mechoulam; Raphael ; et al. | 2008-11-06 |
| Agonists specific for the peripheral cannabinoid receptor Grant 7,214,716 - Fride , et al. May 8, 2 | 2007-05-08 |
| Agonists specific for the periperal cannabinoid receptor App 20050165118 - Fride, Ester ; et al. | 2005-07-28 |
| Agonists specific for the peripheral cannabinoid receptor Grant 6,903,137 - Fride , et al. June 7, 2 | 2005-06-07 |
| Agonists specific for the peripheral cannabinoid receptor Grant 6,864,291 - Fride , et al. March 8, 2 | 2005-03-08 |
| Pharmaceutical compositions comprising cannabidiol derivatives App 20030166727 - Mechoulam, Raphael ; et al. | 2003-09-04 |
| Agonists specific for the peripheral cannabinoid receptor App 20020173528 - Fride, Ester ; et al. | 2002-11-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 